Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 1,135,006 |
|
|||||
| News | - | ||||||
| Day High | 356.71 | Low High |
|||||
| Day Low | 350.225 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Vertex Pharmaceuticals Inc | VRTX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -3.65 | -1.03% | 351.16 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 355.11 | 350.225 | 356.71 | 351.16 | 354.81 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 31,429 | 1,135,006 | US$ 353.35 | US$ 401,057,423 | - | 282.21 - 387.42 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:51:25 | 4 | US$ 353.62 | USD |
Vertex Pharmaceuticals (VRTX) Options Flow Summary
Vertex Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 90.49B | 257.68M | - | 8.99B | 3.32B | 12.89 | 27.24 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Vertex Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical VRTX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 354.95 | 356.71 | 346.285 | 351.31 | 1,250,947 | -3.79 | -1.07% |
| 1 Month | 379.64 | 387.42 | 341.90 | 360.53 | 1,578,497 | -28.48 | -7.5% |
| 3 Months | 344.30 | 387.42 | 341.85 | 359.82 | 1,213,867 | 6.86 | 1.99% |
| 6 Months | 324.47 | 387.42 | 320.01 | 353.49 | 1,151,448 | 26.69 | 8.23% |
| 1 Year | 318.55 | 387.42 | 282.21 | 331.91 | 1,199,375 | 32.61 | 10.24% |
| 3 Years | 227.47 | 387.42 | 176.36 | 257.49 | 1,584,235 | 123.69 | 54.38% |
| 5 Years | 182.60 | 387.42 | 151.80 | 242.81 | 1,550,401 | 168.56 | 92.31% |
Vertex Pharmaceuticals Description
| Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule drugs for the treatment of serious diseases. Its key drugs are Kalydeco, Orkambi, Symdeko, and Trikafta/Kaftrio for cystic fibrosis, where Vertex therapies remain the standard of care globally. In addition to its focus on cystic fibrosis, Vertex is diversifying its pipeline through gene-editing therapies such as CTX001 for beta-thalassemia and sickle-cell disease, small-molecule inhibitors targeting acute and chronic pain using non-opioid treatments, and small-molecule inhibitors of APOL1-mediated kidney diseases. Vertex is also investigating cell therapies to deliver a potential functional cure for type 1 diabetes. |
